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Sterol Carrier Protein-2 Directly Interacts with Caveolin-1 in Vitro and in Vivo†
Minglong Zhou,‡ Rebecca D. Parr,§ Anca D. Petrescu,‡ H. Ross Payne,§ Barbara P. Atshaves,‡ Ann B. Kier,§
Judith M. Ball,§ and Friedhelm Schroeder*,‡
Department of Physiology and Pharmacology, Texas A&M UniVersity, TVMC, College Station, Texas 77843-4466, and
Department of Pathobiology, Texas A&M UniVersity, TVMC, College Station, Texas 77843-4467
ReceiVed October 27, 2003; ReVised Manuscript ReceiVed March 10, 2004

ABSTRACT: HDL-mediated reverse-cholesterol transport as well as phosphoinositide signaling are mediated
through plasma membrane microdomains termed caveolae/lipid rafts. However, relatively little is known
regarding mechanism(s) whereby these lipids traffic to or are targeted to caveolae/lipid rafts. Since sterol
carrier protein-2 (SCP-2) binds both cholesterol and phosphatidylinositol, the possibility that SCP-2 might
interact with caveolin-1 and caveolae was examined. Double immunolabeling and laser scanning
fluorescence microscopy showed that a small but significant portion of SCP-2 colocalized with caveolin-1
primarily at the plasma membrane of L-cells and more so within intracellular punctuate structures in
hepatoma cells. In SCP-2 overexpressing L-cells, SCP-2 was detected in close proximity to caveolin, 48
( 4 Å, as determined by fluorescence resonance energy transfer (FRET) and immunogold electron
microscopy. Cell fractionation of SCP-2 overexpressing L-cells and Western blotting detected SCP-2 in
purified plasma membranes, especially in caveolae/ lipid rafts as compared to the nonraft fraction. SCP-2
and caveolin-1 were coimmunoprecipitated from cell lysates by anti-caveolin-1 and anti-SCP-2. Finally,
a yeast two-hybrid assay demonstrated that SCP-2 directly interacts with caveolin-1 in vivo. These
interactions of SCP-2 with caveolin-1 were specific since a functionally related protein, phosphatidyinositol
transfer protein (PITP), colocalized much less well with caveolin-1, was not in close proximity to caveolin-1
(i.e., >120 Å), and was not coimmunoprecipitated by anti-caveolin-1 from cell lysates. In summary, it
was shown for the first time that SCP-2 (but not PITP) selectively interacted with caveolin-1, both within
the cytoplasm and at the plasma membrane. These data contribute significantly to our understanding of
the role of SCP-2 in cholesterol and phosphatidylinositol targeted from intracellular sites of synthesis in
the endoplasmic reticulum to caveolae/lipid rafts at the cell surface plasma membrane.

Although the plasma membrane lipid bilayer is a matrix
for integrating transport and signaling functions, molecular
details of how lipid organization contributes are only now
being resolved. Cholesterol, classically thought to function
in maintaining optimal membrane fluidity and permeability,
is now being recognized as a major force for organizing
signaling lipids as well as cell signaling and transport proteins
into cholesterol-rich domains termed lipid rafts/caveolae
within the plasma membrane (1, 2). While cholesterol is
randomly distributed across the plane of the bilayer in model
membranes, in plasma membranes (reviewed in refs 3 and
4) and lipid rafts/caveolae (5), cholesterol preferentially
distributes into the cytofacial leaflet (i.e., cholesterol-rich)
by as yet unresolved mechanisms. In contrast, cholesterol
spontaneously distributes into cholesterol-rich (termed lipid
rafts) and cholesterol-poor domains in the lateral plane of
both model membranes (1, 4) and biological membranes
(reviewed in refs 2-4 and 6-11). Lipid rafts/caveolae are
especially rich in lipids involved in intracellular signaling
†
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[phosphatidylinositol (PI), phosphatidylinositol-4-phosphate
(PIP), phosphatidylinositol-4,5-bisphosphate (PIP2), ceramide, and diacylglycerol] (6, 11-14) and signaling proteins
(11, 13). Since disruption of these cholesterol-rich microdomains also inhibits transport and signaling (13), it would
appear that intact lipid rafts/caveolae are essential for
organizing signaling lipids and proteins in close proximity.
Because cholesterol and signaling molecule precursors such
as PI are synthesized in the endoplasmic reticulum, mechanisms must exist for their preferential transport to plasma
membrane caveolae. However, these trafficking pathways
are only beginning to be resolved. Sterol carrier protein-2
and caveolin-1 are two proteins involved in the transfer of
both cholesterol and phosphatidylinositol.
Cholesterol appears to be transported from intracellular
sites to plasma membrane caveolae by both rapid proteinmediated and slow vesicular mechanisms. SCP-21 (reviewed
in refs 7, 15, and 16) and caveolin-1 (as a complex with
chaperone proteins) (17, 18) mediate rapid (half time of 1-2
min) molecular transfer of cholesterol from intracellular
sources to plasma membrane caveolae. In contrast, slow (1520 min) vesicular cholesterol transport occurs via caveolar
vesicles budding from the Golgi (reviewed in ref 11) and
1
Abbreviations: SCP-2, sterol carrier protein-2; PITP, phosphatidylinositol transfer protein.
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vesicles derived from the LDL-receptor-lysosomal endocytic pathway (reviewed in ref 19). Despite the important
role of both SCP-2 and caveolin-1 in cholesterol transfer to
plasma membrane caveolae, it is not known whether these
proteins directly interact for mediating cholesterol traffic to
plasma membrane caveolae.
Phosphatidylinositol transport from its site of synthesis,
the endoplasmic reticulum, to plasma membrane caveolae
has also been proposed to occur by both protein-mediated
molecular transfer and vesicular transfer via caveolin-1
containing vesicles originating from the golgi (reviewed in
refs 20-22). SCP-2 (23) and another protein, phosphatidylinositol transfer protein (PITP) (20, 21, 24), enhance rapid
PI transfer from the endoplasmic reticulum. However, it is
unclear whether these proteins directly interact with caveolin-1 and caveolae at the plasma membrane. For example,
immunolocalization of fixed cells detects highest levels of
PITPR within nuclei and perinuclear golgi, while PITPβ is
primarily distributed to perinuclear golgi (20, 25). Furthermore, neither PITPR nor PITPβ is detected at the plasma
membrane (20, 25). The latter observation is puzzling
especially in view of the fact that PITP is thought to directly
present bound substrate to phospholipase C and to interact
with phosphoinositide kinase signaling complex at the plasma
membrane caveolae (reviewed in refs 20 and 25). Subcellular
fractionation and immunolocalization reveal that nearly half
of total SCP-2 is extraperoxisomal in cytoplasm and/or
associated with endoplasmic reticulum or mitochondria
(reviewed in refs 15 and 16). In contrast, immunolabeling
confocal microscopy detects some SCP-2 at the plasma
membrane (23), and SCP-2 overexpression enhances the
rapid diffusion of ligands (16, 26), suggesting that SCP-2
participates in molecular PI transfer between intracellular
sites and plasma membrane caveolae. Because the limit of
resolution of light microscopy is about 2200 Å, it remains
to be determined whether these observations reflect direct
association of SCP-2 with caveolin-1.
The purpose of the present investigation was to begin to
resolve these issues to determine: (i) whether SCP-2 and
PITP at the plasma membrane are colocalized with caveolin,
(ii) if SCP-2 coimmunoprecipitates with caveolin from cell
lysates, (iii) if SCP-2 is associated with purified plasma
membranes and lipid rafts/caveolae isolated therefrom, (iv)
whether SCP-2 and caveolin are detectable in close proximity
as shown by fluorescence resonance energy transfer (FRET)
and immunogold electron microscopy of intact cells, and (v)
if SCP-2 and caveolin interact directly in a yeast two-hybrid
assay. These studies should contribute significantly to our
understanding of how SCP-2 participates in intracellular
cholesterol trafficking and/or PI trafficking.
MATERIALS AND METHODS
Cells and Media. SCP-2 overexpressing and mocktransfected L-cell fibroblasts (27, 28) were cultured in
Higuchi media supplemented with 10% FBS (Hyclone,
Logan, UT) and 1 × penicillin and streptomycin (Sigma,
St. Louis, MO). SCP-2 overexpressing (28) and mocktransfected McA-RH7777 hepatoma cells (29) were cultured
in DMEM (Gibson, Grand Island, NY) as described (28).
These cell lines were chosen for several reasons. Thus,
fibroblasts represent peripheral cells from which cholesterol
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effluxes readily (i.e., generally having high levels of caveolin1, PITP, and low levels of SCP-2). As expected, control
(mock-transfected) L-cells have very low SCP-2 levels (about
0.008% of total cytosolic protein) and readily detectable
caveolin-1 (23, 30) and PITP (23). In SCP-2 overexpressing
L-cells, the SCP-2 level was increased 4.3-fold to 0.036%
of total cytosolic proteins (reviewed in refs 27 and 31).
Overexpression of SCP-2 results in 4-fold up-regulation of
caveolin-1 (23). Second, hepatoma cells are derived from
liver, a tissue normally containing high levels of SCP-2,
PITP, and very little caveolin-1 (16). While SCP-2 levels
in mock-transfected McA-RH7777 hepatoma cells are
about 20-fold lower than in liver, in SCP-2 overexpressing
McA-RH7777 hepatoma cells SCP-2 levels were similar to
those in liver as detected with Western blot analysis (29).
Overexpression of SCP-2 in McA-RH7777 hepatoma cells
did not alter the level of caveolin-1.
Antibodies. Primary antibodies for imaging and Western
blot assay were as follows: anti-SCP-2 was produced in rats
or rabbit in our own lab following the protocols described
earlier (reviewed in refs 27, 28, 31, and 32). Mouse
monoclonal anti-PITP, mouse monoclonal anti-caveolin-1
rabbit anti-caveolin-1 polyclonal antibody, and anti-flotillin
polyclonal antibody were purchased from Transduction
Laboratories (BD Biosciences-Transduction Lab, San Diego,
CA).
Rat anti-caveolin-1 antiserum was obtained against a 30residue synthetic peptide corresponding to the N-terminal
region of caveolin-1 (Ser-Gly-Gly-Lys-Tyr-Val-Asp-Ser-GluGly-His-Leu-Tyr-Thr-Val-Pro-Ile-Arg-Glu -Gln-Gly-Asn-IleTyr-Lys-Pro-Asn-Asn-Lys-Ala). This peptide [SGGKYVDSEGHLYTVPIREQGNIYKPNNKA] was prepared by solidphase peptide chemistry, HPLC purified, and characterized
by mass spectroscopy following standard laboratory protocols
(33, 34). The full-length peptide product was cross-linked
to keyhole limpet hemocyanin (KLH, Sigma Chemical Co.,
St. Louis, MO) at a ratio of 100 nmol peptide/1 nmol KLH,
emulsified in Freund’s adjuvant (Pierce, Rockford, IL), and
administered by the intramuscular, intraperitoneal, and
subcutaneous routes in Sprague Dawley female rats (Harlan,
Indianapolis, IN). The peptide specificity of the antiserum
was confirmed by ELISA and Western blot analyses.
Rabbit anti-PMP70 was purchased from Zymed (San
Francisco, CA), while sheep anti-bovine catalase was from
Biodesigns (Saco, Maine). Rabbit anti-Na+ K+-ATPase
and anti-SR-B1 were purchased from Novus Biologicals
(Littleton, CO). Secondary antibodies for imaging were as
follows: goat-anti-rabbit-IgG-Rhodamine Red X, anti-mouseIgG-FITC, and anti-mouse IgG-Texas Red were purchased
from Jackson Immunochemistry Laboratories (West Grove,
PA). Goat-anti-rat-IgG-FITC was purchased from Sigma (St.
Louis, MO), while donkey anti-sheep IgG-Alexa568 was
from Molecular Probes (Eugene, OR). Secondary antibodies
for immuno-blotting assay were as follows: three alkaline
phosphatase conjugates, goat anti-mouse-IgG, anti-rat-IgG
and anti-rabbit-IgG, were also purchased from Sigma (St.,
Louis, MO).
Immunolabeling of Cultured Cells for Laser Scanning
Confocal Microscopy. Mock-transfected control and SCP-2
overexpressing hepatoma or L-cells were seeded into four
well-chambered coverglasses (Nunc, Fisher Scientific, Pittsburgh, PA) and cultured to approximately 80% confluency
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in complete Higuchi media. Cells were washed and fixed in
cold methanol/acetone (1:1) as described earlier (48). Rat
anti-SCP-2, rabbit anti-PMP70, and donkey anti-bovine
catalase were diluted at 1:50 in PBS, while mouse anticaveolin-1 and PITP were diluted at 1:100. A 200 µL aliquot
of diluted primary antibodies was added to each well and
incubated at room temperature for 1 h. After five washes
with PBST (PBS, pH, 7.4, 0.05% Tween-20), secondary
antibodies (1:100) were added into each well and incubated
for 1 h at room temperature followed by five washes with
PBS (pH 7.4). Control staining was done with normal rabbit
and mouse sera or by omitting the primary antibodies and
using either or both secondary antibodies. This allowed
optimization of the concentration of secondary antibodies
and hence minimized the nonspecific secondary antibody
staining.
Laser Scanning Confocal Microscopy (LSCM). LSCM was
performed with a MRC-1024 point scanning laser confocal
microscopy system (Bio-Rad, Hercules, CA) equipped with
a Zeiss Axiovert 135 inverted microscope, fitted with 63 ×,
1.4 N.A. oil immersion lens (23, 28, 31, 35, 36). FITC was
excited with a 15 mW Kr-Ar laser using the 488 nm band,
and the emission was detected through a 522/ DF35 filter.
Rhodamine Red X, Texas Red, and Alexa568 were excited
at the 568 nm band of the Kr-Ar laser, and their emission
was detected through a HQ598/40 filter. Confocal images
were acquired with Laser Sharp Software (Bio-Rad) and
analyzed with Laser Sharp (Bio-Rad), Metamorph (Universal
Imaging, the Imaging Division of ASI, Nikon In., Melville,
NY), and Adobe Photoshop (Adobe System Inc., Seattle,
WA) softwares as described earlier (23, 28, 31, 35, 36).
Images were acquired and analyzed using LaserSharp (from
Bio-Rad) and MetaMorph Image Analysis (from Advanced
Scientific Imaging, Meraux, LA) softwares. Analysis of
SCP-2 colocalization with caveolin at the plasma membrane
was performed on an average of 20 cells from four different
wells, and the results obtained were shown for a representative set of cells. LaserSharp version 3.0 software was used
for colocalization analysis and two values (colocalization
coefficients) were calculated based on Pearson’s correlation
coefficient, which is a well-established means of describing
the degree of overlap between patterns or images (37). The
software calculated the colocalization coefficients for two
different fluorophores, designated red and green herein,
according to the following equations: Cred ) ΣRi,coloc/ΣRi
and Cgreen ) ΣGi,coloc/ΣGi. In these equations, ΣRi,coloc
represents the sum of intensities of all red pixels, which also
have a green component; ΣRi is the sum of all the red pixels
in the image; ΣGi,coloc represents the sum of intensities of all
green pixels that have a red component; and ΣGi is the sum
of intensities of all green pixels in the image. The coefficients
generated by LaserSharp have values between 0 and 1; a
value of 0 indicates that there is no colocalization, while a
value of 1.0 means there is complete colocalization.
Fluorescence Resonance Energy Transfer (FRET)
Microscopy. FluorLink-AB Cy3 and Cy5 labeling Kits
were purchased from Amersham Pharmacia Biotech Inc.
(Piscataway, NJ). Rabbit anti-SCP-2-Cy3/Cy5, mouse anticaveolin-1 IgG-Cy5, and mouse anti-PITP-Cy3 conjugates
were prepared as indicated by the Amersham labeling kit
instructions. SCP-2 overexpressing L-cells were cultured in
chambered coverglass to about 80% confluency. The cells
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were washed, fixed, and blocked as described earlier (23)
followed by incubation in 1:10 diluted Cy3 and Cy5
conjugates for 1 h at room temperature. The cells were
washed 5 times in PBS. Fluorescence resonance energy
transfer (FRET) was performed with the MRC-1024 LSCM
system by the combined acceptor and donor photobleaching
methods (pBDIM) (79-81). Prebleach Cy3 (donor) and Cy5
(acceptor) were excited at 567 and 648 nm, respectively, and
emissions were detected through HQ598/40 and 680/30 nm
filters, respectively. A sensitized Cy5 image was also
obtained upon Cy3 excitation at 567 nm and detection of
Cy5 emission through a 680/30 nm filter. To perform FRET,
a field of interest was selected and rendered free of Cy5 by
bleaching using repeated scanning with the 647 nm laser
band at 100% power for 15-20 min. The post-bleached Cy3
and Cy5 images were obtained with the same filter settings
as described previously. The FRET efficiencies (Ei) in pixel
i in selected cells (n > 25) were calculated from image
arithmetic of the prephotobleach (Ipre,i) and postphotobleach
(Ipst,i) Cy3 images (38-40) according to eq 1.

Ei ) (Ipst,i - Ipre,i)/Ipst,i

(1)

where Ei was calculated from n > 20 cells. The distance
between two fluorophores was determined from the energy
transfer efficiency Ei, which is related to the distance r
separating a given donor and acceptor pair according to eq 2.

Ei ) 1/[1 + (r/Ro)6]

(2)

where Ro is the distance for 50% energy transfer efficiency.
For the Cy3 donor and Cy5 acceptor pair, Ro is 50 Å (38).
When the distance between donor and acceptor is larger than
2 × Ro, no FRET occurs (41). Since Cy3 and Cy5 labeling
and purification of antibodies according to the manufacturer’s
directions yielded diluted Cy3- and Cy5-tagged antibodies,
a range of dilutions was tested for the Cy3- and Cy5-labeled
antibodies. A 1:10-1:20 dilution of the Cy3- and Cy5labeled antibodies was optimal for minimizing nonspecific
staining and maximizing the fluorescent signals. Normal
rabbit and mouse sera were also included in the blocking
buffer to ensure the specificity of staining. Control experiments for cross-talk were performed by recording donor
(Cy3) only slide, acceptor (Cy5) only slide, and slide with
both donor and acceptor.
Immunoelectron Microscopy. LR White resin, Lowicryl
HM20 resin, and gold-labeled polyclonal antibodies against
rabbit IgG and rat IgG (Aurion, Wageningen, The Netherlands), were purchased through Electron Microscopy Sciences (Fort Washington, PA). Transfected L-cell fibroblasts
and T7 hepatoma cells overexpressing SCP-2 were cultivated
on poly-l-lysine coated glass slides and fixed in 4%
formaldehyde, 0.1% glutaraldehyde in 0.1 M sodium phosphate buffer, pH 7.4, for 4 h at 4 °C. The cells were stained
at 24 °C with 0.5% uranyl acetate in 70% ethanol for 30
min, dehydrated in a graded ethanol series, and then
embedded in LR White acrylic resin at 48 °C for 2 days.
L-cells and T7 hepatoma cells also were prepared for
immunolocalization by low-temperature embedment at -35
°C in Lowicryl HM20 with polymerization by UV light.
Ultrathin tissue sections (70-90 nm) were placed on
Formvar-coated nickel grids and immunogold stained with
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anti-SCP2 antiserum raised in rabbit (diluted 1:25-1:40)
alone or in a mixture with anti-caveolin antiserum raised in
rat (diluted 1:40). These sections were washed and incubated
with a mixture of goat anti-rabbit IgG conjugated to 15 nm
gold particles and goat anti-rat IgG conjugated to 6 nm gold
particles. Control incubations were also performed without
primary antibodies.
Immunoprecipitation and Western Blot Analysis. SCP-2
overexpressing L-cells were cultured in five 75 cm2 tissue
flasks to confluence. The cells were washed with cold PBS
(pH 7.4) three times followed by incubation for 10 min on
ice in 1 mL/flask of single-detergent lysis buffer (42). The
lysates were transferred into 1.5 mL tubes, and cell debris
was pelleted down at 1000g for 5 min. The immunoprecipitation is performed following the procedure described by ref
42. The cell lysates were precleared with normal rabbit serum
to reduce the nonspecific formation of the target proteinsIgG-protein-A-sepharose beads (Sigma, St, Louis, MO).
The supernatants were then transferred into fresh tubes
followed by immunoprecipitation with rabbit anti-SCP-2 or
rabbit anti-caveolin-1 polyclonal antibodies. The immunoprecipitated protein-antibody complexes were removed from
protein-A beads by adding 50 µL of 1 × SDS sample buffer
and heating at 100 °C for 5 min. After centrifugation at 12
000g for 20 s, the samples were loaded onto SDS-15%
polyacrylamide gel for resolution. The proteins were then
transferred to nitrocellulose membranes in 1 × transfer buffer
(42). The nitrocellulose membranes were then blocked in
2% BSA-PBST (PBS, pH 7.0, 0.05% Tween-20) overnight
at 4 °C, followed by incubating in 1:1000 diluted mouse
anti-caveolin-1 monoclonal antibody or 1:1000 diluted rat
anti-SCP-2 polyclonal antibody for 2 h at room temperature.
The membranes were then washed 5 times with PBST and
then incubated in 1:5000 diluted goat-anti-rat-IgG or goat
anti-mouse-IgG alkaline phosphatase conjugates for another
2 h. The membranes were washed 5 times in PBS and
developed in BCIP/NBT (Sigma, St. Louis, MO).
Biochemical Fractionation of L-Cells OVerexpressing
SCP-2: Plasma Membranes, CaVeolae/Lipid Raft Domains,
and Nonraft Domains. A two-step procedure was used to
biochemically fractionate SCP-2 overexpressing L-cells to
obtain (i) plasma membranes isolated without the use of
detergents (30, 43) and (ii) lipid rafts/caveolae and nonraft
domains isolated from the purified plasma membranes by
concanavalin-A (con-A) sepharose 4B affinity chromatography (6). Cells were cultured grown on 12 culture trays
(200 × 200 mm, Nalge-Nunc, Milwaukee, WI) for 96 h,
washed with PBS, and cultured overnight in serum-free
medium. Cells were then rinsed 2 × with PBS, scraped into
PBS with protease inhibitor (0.2 µM PMS-F), and sedimented for 5 min at 1000g, and the resultant cell pellet was
resuspended in buffer A (0.25 M sucrose/5 mM TRIS-HCL,
pH 7.8). Cells were then homogenized in a N2 Bomb Cell
Disrupter (Parr Instrument Co., Moline, IL) with 40 psi of
N2 for 13 min. After sedimentation at 1000g for 10 min,
the postnuclear supernatant was collected, placed on top
of 30% Percoll in sucrose/TRIS, and centrifuged at
70 000g for 30 min in an SW40Ti rotor on a model XL90
ultracentrifuge (Beckman Instruments, Fullerton, CA). The
plasma membrane enriched fraction located at the interphase
between the Percoll and the sample layer was collected,
sonicated briefly (15 s pulse 3 times over 3 min) using a
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Fisher 550 Sonic Dismembrator (Fisher Scientific, Pittsburgh,
PA), and subjected to con-A sepharose affinity chromatography basically as described (6, 44). The nonadherent
fractions eluting from the column were designated nonraft
fractions. The conA adherent fraction, eluted with 0.5 M
R-methylmannoside, was designated the caveolae/lipid raft
enriched fractions. These designations were based on marker
assays for caveolae/lipid rafts (caveolin-1, flotillin, SR-B1)
and nonrafts (Na+,K+-ATPase) determined by Western blot
analysis (see next). Both nonraft and caveolae/lipid raft
fractions were sedimented at 70 000g for 15 h, the pellets
were resuspended in minimal amount of wash buffer (buffer
X with 1 mM EDTA without MgCl2 or MnCl2), and excess
Mn2+ resulting in formation of a brown precipitate was
removed by briefly centrifuging the sample at 10 000 rpm
for 2 min. Western blotting to determine the distribution
of marker proteins typically found in caveolae/lipid raft
[caveolin-1 (6, 45, 46), flotillin (47), or SR-B1 (6, 11)] and
nonlipid raft (Na+,K+-ATPase) (6, 45) showed that purified
plasma membranes were enriched up to 10-fold in these
markers, especially flotillin and Na+,K+-ATPase, consistent
with the previous citations. The conA nonadherent fraction
was highly enriched up to 20-fold in the nonlipid raft marker
Na+,K+-ATPase but highly reduced in caveolae/lipid raft
markers (caveolin-1, flotillin, or SR-B1). In contrast, the
conA adherent fraction was enriched up to >10-fold in
caveolae/lipid raft markers (caveolin-1, flotillin, or SR-B1)
and reduced in nonraft marker (Na+,K+-ATPase) as compared to the nonadherent fraction and cell homogenate.
Yeast Two-Hybrid Assay. All reagents and basic procedures (48-50) for the yeast two-hybrid assay were performed
exactly as described in Materials and Methods supplied with
the instruction kit Proquest Two-Hybrid System with Gateway Technology (Invitrogen, Carlsbad, CA).
Strains, Media, and Microbiological Techniques. Saccharomyces cereVisiae strain MaV203 (MATR, leu2-3, 112,
trp1-901, his3∆200, ade2-101, gal4∆, gal80∆, SPAL10::
URA3, Gal1::lacZ, HIS3UAS GAL1::HIS3@LYS2, can1R, cyh2R)
was used to test for interactions of caveolin-1 and SCP-2. A
panel of MaV103 (MATa) control strains, containing the
same genotype as MaV203 expressing a GAL4 DNA binding
fusion protein (DB-X) and a GAL4 transcription activating
fusion protein (AD-Y) fusion protein with a spectrum of
interaction strengths, were patched onto all assay plates (48).
The plasmid vectors used were pPC97 (GAL4-DB, LEU2),
pPC97-CYH2S, and pPC86 (GAL4-AD, TRP1) (48, 49, 51).
pDBleu was derived from pPC97 (Invitrogen). All plasmid
manipulations were performed according to standard protocol
for Escherichia coli strains DH5R and electroMAX DH10B
cells (48). Induction of the HIS3 and URA3 reporter genes
allowed two-hybrid-dependent transcription activation to be
monitored by cell growth on plates lacking histidine or uracil,
respectively. The induction of the lacZ gene was demonstrated qualitatively using the substrate X-gal (5-bromo4chloro-3-indolyl-β-d-galactopyranoside). This resulted in
yeast colonies turning a blue color. Likewise, a quantitative
assay using the substrate, CPRG (chlorophenol red β-D
galactopyranoside). This resulted in the production of a
reddish brown color.
HIS3 encodes the enzyme, imidazole glycerol phosphate
dehydratase, that is inhibited in a dose-dependent manner
by 3-amino-1,2,4-triazole (3-AT) (52). To increase the
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sensitivity of the HIS3 reporter gene, the MaV203 strain
expresses a basal level of HIS3 that can be titered out using
increasing concentrations of 3AT to a point at which growth
in the absence of histidine is inhibited. Any growth past this
concentration indicates that DB-X (the Gal4 DNA binding
domain fusion protein) functions as a transcription activator
by itself. To ensure that the DB-X fusion protein does not
function as a transcription activator, an inhibition of growth
on medium lacking histidine (CSM-Leu-Trp-His) with
increasing amounts of 3-amino-1,2,4-triazole (3AT) was
evaluated. The following levels of 3AT where included with
each colony tested: CSM-Leu-Trp-His + 100 mM 3AT, 75
mM 3AT, 50 mM 3AT, 25 mM 3AT, and 12.5 mM 3AT.
Yeast and bacterial strains were propagated using established methods (Invitrogen ProQuest Two-Hybrid System
with Gateway Technology manual). The enriched yeast
medium YPAD (yeast extract(Difco)/peptone(Difco)/adenine/
2% dextrose) and CSM (complete synthetic medium) lacking
the appropriate amino acids have been described (50).
SCP-2 Clones. The SCP-2 cDNA was excised from the
mammalian SCP-2 overexpression plasmid pKJ1∆F (27)
using SmaI and XhoI, ligated into the XmnI and XhoI sites
of the Gateway System entry clone, pENTR11 (Invitrogen,
CA), transformed into DH5R E. coli, and grown under
kanamycin selection. The new plasmid, pENTR-SCP2,
was restriction enzyme digested, sequence verified, and
used to subclone SCP-2 into the expression vectors of the
Gateway Expression System, pDEST22 (with the activation
domain of the transcription factor, Gal4) and pDEST32 (with
the binding domain of the transcription factor, Gal4) for
expression in the ProQuest Two-Hybrid System with Gateway Technology (Invitrogen). The recombinant plasmids,
pDEST22-SCP2 and pDEST32-SCP2, were extracted from
E. coli using the Wizard Miniprep Kit and restriction enzyme
digested with EcoRV, KpnI, and XhoI (Promega) prior to
sequence confirmation.
CaVeolin-1 Clones. The caveolin-1 gene was amplified
from the vector, pCCaveolin-1 (a gift from Dr. R. G.
Anderson, Southwestern Medical Center, Dallas, TX). The
caveolin-1 PCR product was generated using Pfu DNA
polymerase (Stratagene, La Jolla, CA) and the primers BP12 (5′-ATGTCTGGGGGCAAATA-3′) and BP13 (5′-atatctctgagTTATATTTCTTTCTGCAAG TTGAT-3′) by introducing
a blunt 5′ end and a 3′ XhoI site for cloning. The thermocycle
parameters were as follows: 98 °C for 45 s, 97 °C for 45 s,
50 °C for 45 s, 72 °C for 2 min, cycle for 26 times, and 72
°C for 10 min. The PCR product was purified using a Wizard
PCR Prep column (Promega, Madison, WI), quantitated on
a 0.7% agarose gel, restriction enzyme digested, purified
using a Wizard PCR Prep column, and ligated into the XmnI/
XhoI sites of the Gateway System entry clone, pENTR11
(Invitrogen). The new plasmid, pENTR-caveolin-1 was
restriction enzyme digested, sequence verified, and used to
subclone caveolin-1 into the expression vectors of the
Gateway Expression System, pDEST22 and pDEST32 as
described previously.
Yeast Two-Hybrid Assay. The ProQuest Two-Hybrid
System (Invitrogen) was used to identify the potential
interactions of SCP-2 and caveolin-1. SCP-2 was fused to
the Gal4 activation domain (amino acid 768-881), and
caveolin-1 was fused to the Gal4 binding domain (amino
acid 1-147) and transformed into S. cereVisiae (53). Briefly,
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S. cereVisiae MaV203 was grown in YPAD overnight at 30
°C; diluted to an OD600 of 0.5, and incubated at 30 °C with
shaking to an OD600 of 2. The cells were pelleted, washed
with dH2O, resuspended in 1 mL of 100 mM lithium acetate
(LiAc), pelleted, and resuspended in 0.4 mL of 100 mM
LiAc, and 50 µL aliquots were placed into microcentrifuge
tubes. The cells were pelleted, and the following solutions
were added in order: 240 µL of 50% PEG (3350 mw); 36
µL of 1 M LiAc, 25 µL of salmon sperm DNA (2 mg/mL);
50 µL of dH2O; and 100 ng of plasmid DNA.
A series of yeast transformations were performed to
determine the efficiency of the transformation protocol and
to test the individual plasmid efficiency of transformation
(data not shown). Both fusion proteins were independently
transformed into S. cereVisiae MaV203 to test each clone
for self-activation and determine the concentration of 3-amino1,2,4-triazole (3AT) required to titrate basal HIS3 expression
levels. Both fusion proteins were coexpressed in MaV203.
Initially the transformants were grown on CSM-Leu-Trp
at 30 °C for 2-5 days to identify colonies containing both
the activating and the DNA binding domain fusion proteins
(AD-Y and DB-X). Cotransformed yeast was patched onto
master plates, CSM-Leu-Trp, along with five different control
yeast containing pairs of control plasmids that ranged from
very strong to no interacting plasmids at 30 °C for 48-72
h. The colonies were replica-plated onto media selective for
the presence and interaction of both plasmids (CSM-LeuTrp-Ura; CSM-Leu-Trp-His + 3AT [12.5, 25, 50, 75, and
100 mM 3AT]; YPAD plates contain a nitrocellulose filter
for β-galactosidase assays; and CSM-Leu-Trp + 0.2%
5FOA) according to the ProQuest Two-Hybrid System with
Gateway Technology manual (Invitrogen).
β-Galactosidase Assays. The production of β-galactosidase
was detected both qualitatively and quantitatively on colonies
grown on nitrocellulose membrane filters on YPAD plates
using the substrate X-gal (5-bromo-4chloro-3-indolyl-β-dgalactopyranoside) and in liquid culture using the substrate
CPRG (chlorophenol red β-d-galactopyranoside), respectively, as described by the manufacturer (Invitrogen).
Verification of Candidate Clones. The yeast colonies that
demonstrated protein-protein interactions with the induction
of the URA3, HIS3, and β-galactosidase genes were grown
in liquid CSM-Leu-Trp medium, and the plasmids were
extracted as previously described (94). The recovered plasmids were electroporated into ElectroMAX DH10B cells
according to the manufacturers’ protocol (Invitrogen), restriction enzyme digested, and sequence verified (Gene
Technology Laboratory, Texas A & M University, College
Station, TX).
Yeast Two-Hybrid Western Blot Assays. Yeast protein
extracts were prepared using the Zymo Yeast Protein
Extraction kit (Zymo Research, Orange, CA) and used in
Western blot assays to detect SCP2- and caveolin-1 fusion
proteins. In brief, cells were grown in YPAD medium
overnight at 30 °C, and 1 × 106 cells were pelleted. Y-Lysis
buffer and zymolyase were added to the samples and
incubated at 37 °C for 1 h. The cells were then centrifuged
at 400g for 5 min, and supernatant was removed. The
pellet was resuspended into 1 × SDS-PAGE sample buffer,
boiled for 10 min, and separated on a 12% SDS-PAGE.
Proteins were transferred to nitrocellulose and probed with
rabbit polyclonal anti-SCP-2 antibodies (74, 76-78). Pri-
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mary antibodies were detected with horseradish peroxide
(HRP)-conjugated goat anti-rabbit immunoglobulin (IgG)
antibody (Pierce, Rockford, IL) followed by addition of the
SuperSignal West Pico Chemiluninescent Substrate (Pierce),
and bands were visualized using X-OMAT film (Kodak).
The same yeast two-hybrid assays were performed with
pDEST22-caveolin-1 and pDEST32-SCP2 to verify positive
interactions in both directions.
RESULTS
Intracellular Distribution and Colocalization of SCP-2
with CaVeolin-1 in Hepatoma Cells and L-Cell Fibroblasts: Immunofluorescence Confocal Microscopy. The
intracellular distribution of SCP-2 and caveolin-1 was
examined in mock-transfected McA-RH7777 hepatoma and
mock-transfected L-cells by immunolocalization and laser
scanning confocal microscopy (LCSM). As indicated in the
Materials and Methods, these cells were chosen because their
relative proportions of SCP-2 and caveolin differ significantly: McA-RH7777 hepatoma cells contain significantly
more SCP-2 than L-cells; L-cells contain significantly more
caveolin than hepatoma cells. Hepatoma and L-cells were
double immunolabeled with anti-sera to SCP-2 and caveolin-1 followed by reaction with secondary antibodies conjugated to Rhodamine Red X and FITC, respectively.
Although SCP-2 was detected primarily in the perinuclear
region, in punctuate intracellular structures, and diffusely
throughout the cytoplasm of hepatoma cells (Figure 1A Red),
a small but significant amount of SCP-2 was visualized at
plasma membrane (Figure 1A, arrows). To determine if the
plasma membrane associated SCP2 might be more readily
visualized in cells containing less SCP-2, this experiment
was repeated with mock-transfected L-cells. While the
majority of SCP-2 was also detectable in the perinuclear
region, in punctuate intracellular structures, and throughout
the cytoplasm of L-cells (Figure 1E, red), plasma membrane
staining of SCP-2 was more evident in L-cells (Figure 1E,
arrows) than in hepatoma cells (Figure 1A, arrows).
While caveolin-1 levels in hepatoma cells were low,
nevertheless caveolin-1 was detectable and primarily distributed in the cytoplasm, both diffusely and as punctuate
structures (Figure 1B, green). However, a small amount of
caveolin-1 was detected at the plasma membrane clearly
visible as a ring at the cell surface (Figure 1B, arrows). The
relatively caveolin-1-rich L-cells showed much more caveolin-1 staining intensity, especially in the perinuclear region
and diffuse punctuate throughout the cytoplasm (Figure 1F).
Again, however, caveolin-1 was distinct caveolin staining
was observed at the plasma membranes (Figure 1F, arrows).
To visualize colocalization of SCP-2 with caveolin-1 in
hepatoma and L-cells, the simultaneously acquired red (SCP2) and green (caveolin-1) images were superimposed (Figure
1C,G). While these images showed primarily separate (i.e.,
noncolocalized) SCP-2 (red pixels) and caveolin-1 (green
pixels), a significant amount of colocalized SCP-2/caveolin-1
was visible as yellow pixels (Figure 1C,G). To more clearly
distinguish and determine the distribution of the colocalized
SCP-2/caveolin-1, the most colocalized yellow pixels were
displayed separately (Figure 1D,H). In hepatoma cells, the
colocalized SCP-2/caveolin-1 (yellow pixels) were distributed
primarily in distinct punctuate structures (Figure 1D) but less

FIGURE 1: Intracellular distribution of SCP-2 and caveolin-1 in
hepatoma and L-cells. In fixed cells (hepatoma cells in panels A-D
and L-cells in E-H), caveolin-1 was probed with mouse anticaveolin-1-IgG and goat anti-mouse-IgG-FITC (green), while SCP-2
was probed with rat-anti-SCP-2 and goat anti-rat-IgG- Rhodamine
Red X (red). Panels A and E: localization of SCP-2 in hepatoma
(A) and L-cells (E). Panels B and F: localization of caveolin-1 in
hepatoma (B) and L-cells (F). Panels C and G: overlay of SCP-2
(red) and caveolin (green) images for hepatoma (C) and L-cells
(G). Panels D and H: images obtained by selecting the pixels with
high fluorescence intensities for both red and green fluorophores
in panels C and G, respectively.

so at the plasma membrane (Figure 1D, arrows). In contrast,
in L-cells the colocalized SCP-2/caveolin-1 was significantly
more concentrated at the plasma membrane (Figure 1H,
arrows). Quantitative pixel fluorogram analysis within select
plasma membrane regions showed that an average of 24.8
( 13.4% of SCP-2 -pixels were colocalized with 75.6 (
15.3% of caveolin-1-pixels within the hepatoma cell plasma
membrane (Table 1). In L-cell plasma membranes, 86.7 (
9.9% of SCP-2-pixels were colocalized with 87.6 ( 10.9%
of caveolin-1-pixels (Table 1). When SCP-2 was overexpressed in hepatoma or L-cells and intracellular localization
was examined as stated previously, again significant amounts
of SCP-2 and caveolin-1 were detected at the plasma
membrane, and within the plasma membrane, much of the
SCP-2 was colocalized with caveolin-1 (data not shown).
These data suggest that both the qualitative and the quantitative distribution of SCP-2 and caveolin-1 were cell-type
dependent. Plasma membranes of cells containing little
SCP-2 but much caveolin-1 (i.e., L-cells) exhibited 3.5-fold
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Table 1: Colocalization Coefficients for SCP-2, PITP, and
Caveolin-1 at the Plasma Membranes of Hepatoma and L-Cells
colocalization coefficient (%)a
colocalized proteins
(protein1/protein2)
SCP-2/caveolin-1
SCP-2/PITP
PITP/caveolin-1

hepatoma cells
protein1

protein2

L-cells
protein1

protein2

24.8 ( 13.4 75.6 ( 15.3 86.7 ( 9.9 87.6 ( 10.9
80.1 ( 13.8 46.6 ( 26.9 86.2 ( 14.8 32.9 ( 19.2
72.2 ( 23.0 81.4 ( 11.3 77.3 ( 16.4 86.1 ( 9.0

a
Regions of interest at the plasma membrane level were selected
from 20 cells and LaserSharp version 3.0 software was used for
calculation of colocalization coefficients therein as described earlier
(37) and detailed in Materials and Methods.

more colocalized SCP-2/caveolin-1 than plasma membranes
of cells containing high levels of SCP-2 but relatively little
caveolin-1 (i.e., hepatoma cells). However, in both cases at
least part of SCP-2 was structurally colocalized with caveolin-1, primarily at the plasma membrane in L-cells, and more
so in punctate (vesicles) structures containing caveolin-1 in
hepatoma cells. While this suggests that perhaps SCP-2 may
directly interact with caveolin-1, the limit of resolution of
light microscopy (2200 Å) precluded a definitive interpretation.
Determination of Intermolecular Distance between SCP-2
and CaVeolin-1 in L-Cells: Fluorescence Resonance Energy
Transfer (FRET). While double immunolabeling revealed that
in the plasma membrane of both hepatoma and L-cells a high
percentage of SCP-2 was colocalized with caveolin-1, the
limit of resolution of light microscopy (i.e., 2200 Å) did not
permit conclusion of whether SCP-2 interacts/binds directly
with caveolin-1. To distinguish this possibility, laser scanning
confocal microscopy fluorescence resonance energy transfer
(FRET) was performed to determine the intermolecular
distance between SCP-2 and caveolin-1 in L-cells. FRET
between donor and acceptor fluorescent molecules varies in
a highly distance sensitive manner (1/R6) and is dictated by
the spectral parameter Ro, the distance at which the FRET
efficiency is 50% (38-40, 54). Since Ro is characteristic for
any given specific donor/acceptor pairs, anti-caveolin-1 and
anti-SCP-2 antibodies were conjugated with Cy3 (donor) and
Cy5 (acceptor), respectively, as described in Materials and
Methods. The Cy3/Cy5 donor/acceptor tags were chosen
because (i) these small fluorophores do not significantly alter
protein size or charge and (ii) the Cy3/Cy5 pair maximally
transfers fluorescence energy when two molecules are <50
Å apart and very weakly transfer energy when two molecules
are >72 Å apart (38). Efficient FRET is expected to occur
from Cy3 to Cy5 only if proteins immunolabeled with these
antibody-coupled tags are in very close proximity. The
intracellular distributions of Cy3-anti-SCP-2 (donor) (Figure
2A) and Cy5-anti-caveolin-1 (acceptor) (Figure 2C) were
basically similar to those detected by primary antibody/
tagged-secondary antibody techniques in L-cells (Figure 1).
Some differences such as a higher labeling inside nuclei by
Cy5-anti-caveolin-1 (Figure 3) than with FITC-anti-IgGanticaveolin-1 (Figure 1) were due primarily to two factors:
(i) differences in quantum yield between the Cy5 and Cy3
(Figure 3) versus FITC and rhodamine red (Figure 1) and
(ii) higher laser excitation power and increased detection
sensitivity (iris, gain, etc.) required to detect FRET. FRET
emission intensities are normally much weaker than emission
resulting from direct excitation of the fluorophores. Never-

FIGURE 2: Fluorescence resonance energy transfer (FRET) between
Cy3-labeled SCP-2 and Cy5-labeled caveolin-1 in L-cells. SCP-2
overexpressing L-cells were fixed and labeled with anti-SCP-2Cy3
and anti-caveolin-1-Cy5 conjugates. FRET was detected as described in the Materials and Methods. Cy3 and Cy5 emission images
were detected through HQ590/40 and 680/20 filter, respectively.
Panel A: Cy3 (SCP-2) emission acquired with 568 nm band
excitation, showing SCP-2 distribution. Panel B: Cy5 (caveolin1) sensitized emission image detected with Cy3 excitation at 568
nm, indicating energy transfer from Cy3 to Cy5. Panel C: Cy5
emission acquired with direct excitation at 647 nm, showing the
caveolin-1 distribution. Panel D: Cy3 emission image acquired with
direct excitation at 568 nm after completely bleaching Cy5. Panel
E: postbleach Cy5 emission acquired with excitation of Cy3 at
568 nm; no sensitized emission was observed. Panel F: postbleach
Cy5 emission acquired with excitation at 647 nm, indicating the
total bleaching of the Cy5 fluorescent molecules. Panels G and H:
Cy3 fluorescence image with direct excitation of Cy3 at 567 nm,
before (G) and after (H) Cy5 photobleach. The images are showed
in pseudocolors, which indicate the level of fluorescence intensity
on a scale from low (blue and green pixels) through medium (yellow
pixels) to high (red pixels) intensity values.

FIGURE 3: Immunogold electron microscopy of SCP-2 and caveolin-1 in L-cells overexpressing SCP-2. Panels A and B are
representative images wherein antigenic sites of SCP2 were labeled
with 15 nm gold particles and sites of caveolin were labeled with
6 nm gold particles as described in Materials and Methods. Groups
of colocalized antigens at the plasma membrane are indicated by
arrows and enlarged in the insets. Panel C: antigenic sites of SCP2
were labeled by 15 nm gold particles in peroxisomes of the L-cells.
Bar ) 100 nm, inset images are enlarged 3×.

theless, the overall patterns of SCP-2 and caveolin-1
distribution imaged by Cy3 and Cy5 labeled secondary
antibodies were basically similar to those imaged by FITC
and rhodamine red secondary antibodies.

SCP-2 Interacts with Caveolin-1
First, FRET was observed as the sensitized emission of
the acceptor when the donor was excited. Cy3-labeled SCP-2
was excited at 568 nm, and an image of Cy3-labeled SCP-2
emission was acquired through a 590/40 nm band filter
(Figure 2A), while simultaneously, the emission of Cy5labeled caveolin-1 was recorded through a 680/30 nm filter
(Figure 2B). Since Cy5 is not excited at 568 nm, this Cy5
image represented FRET-sensitized emission of Cy5 upon
Cy3 excitation at 568 nm wavelength. As indicated by the
arrows in Figure 2B, caveolin-1 detected by sensitized
emission appeared distributed mostly at the plasma membranes of L-cells, clearly indicating that at the plasma
membrane the SCP-2 molecules were very close to caveolin-1 (i.e., within less than 100 Å, the limit of FRET
sensitivity). By directly exciting Cy-5-anti-caveolin-1 at 647
nm, the fluorescence image of caveolin-1 showed its
distribution at the plasma membranes of L-cells but additionally at the peripheral regions of the cytoplasm and even inside
nuclei at low extent (Figure 2C).
Second, FRET was observed as an increase in donor
emission upon prebleaching the acceptor. Cy5-labeled caveolin-1 emitted strongly when Cy5 was directly excited at
647 nm (Figure 2C), a wavelength at which Cy3 was not
excited. The Cy5 fluorescent molecules in the desired field
were photobleached by repeat scanning with 647 nm
wavelength for 15 min at laser power of 100%. After
photobleaching, no Cy5 signal was detected (Figure 2F). The
same photobleached area was then excited with 568 nm (Cy3
excitation), and a postbleach Cy3-labeled SCP-2 image was
acquired (Figure 2D). The postbleach Cy3 image intensity
(Figure 2D) was much stronger than prebleach image
intensity especially in the areas indicated by arrows in Figure
2A, consistent with FRET between Cy3-tagged SCP-2 and
Cy5-tagged caveolin-1. The increase in donor (Cy3) fluorescence intensity after acceptor (Cy5) photobleach can be
easily observed by comparing the images in Figure 2G
(prephotobleach) and Figure 2H (postphotobleach): processed images are shown in pseudocolors that indicate the
level of fluorescence intensity on a scale from low (blue and
green pixels) to medium (yellow pixels) and high (red pixels)
intensity values. In Figure 2H (post Cy-5 photobleach), many
more yellow and red pixels corresponding to SCP-2 appeared
along the plasma membrane (as indicated by arrows). The
image pixel intensities of pre- and postbleach Cy3 (obtained
through Metamorph software as described in Materials and
Methods) were then used to calculate FRET efficiency
according to eq 1. The FRET efficiency was as high as 54
( 6% (n ) 25 cells). The intermolecular distance (r) between
SCP-2 and caveolin-1, calculated using eq 2, was determined
to be 48 ( 4 Å.
Proximity between SCP-2 and CaVeolin-1 at the Plasma
Membrane: Immunogold Electron Microscopy. To confirm
that SCP-2 detected at the plasma membrane was in close
proximity to caveolin-1, L-cells overexpressing SCP-2 were
examined by immunogold electron microscopy. The cells
were cultured on poly-l-lysine coated glass slides, stained
with primary antibodies (i.e., rabbit anti-SCP-2 and rat anticaveolin-1), stained with secondary antibodies (i.e., goat antirabbit IgG conjugated to 15 nm gold particles and goat antirat IgG conjugated to 6 nm gold particles), and examined
by electron microscopy as described in Materials and
Methods. Although the majority of SCP-2 was intracellular,
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representative electron micrographs showed that both SCP-2
and caveolin-1 were detected in close proximity at the plasma
membrane (Figure 3A,B). The intermolecular distance
between 15 nm gold particles (detecting SCP-2) and 6 nm
gold particles (detecting caveolin-1) determined in six
examples from several cells ranged from about 100-240 Å.
This range was well within that established for caveolae by
morphometric analysis of electon microscrographs, 60-80
nm (13, 55), and by other techniques (56-58). The rat antiSCP-2 gold particles closest intermolecular distance (r)
between SCP-2 and caveolin-1 was within 100 Å. This
distance was somewhat larger than observed by FRET due
to (i) repulsive forces between the colloid gold spheres, (ii)
the much greater size of the colloidal gold spheres than Cy3
and Cy5 used in FRET, and (iii) the fact that the immunogold
measurements were from a much more limited number of
sites than represented in the FRET measurements. In
summary, the immunogold electron microscopy data indicated that SCP-2 and caveolin-1 were localized in the plasma
membrane in regions well within the size of caveolae. Within
these plasma membrane regions, some but not all of the
SCP-2 was in very close proximity to caveolin-1, thus
supporting the FRET measurements.
Specificity of SCP-2 Intracellular Distribution and Colocalization with CaVeolin-1 as Compared to that of
Another PI Transport Protein: Phosphatidylinositol Transfer
Protein (PITP). To determine the specificity of SCP-2
colocalization with caveolin-1, the distribution of PITP,
another protein that also binds and transfers PI (24, 48, 59,
60), was examined. Since the two isoforms of PITP differently distribute in some cell lines (62) and to ensure the
specificity of the antigen-antibody reaction, a commercially
available monoclonal anti-PITP antibody was used for
immunolabeling. This anti-PITP antibody immunoreacted
with both PITPR and PITPβ (23). While PITP was localized
mainly throughout the cytoplasm (Figure 4A,E), small
amounts of PITP were detectable at the plasma membranes
in both hepatoma (Figure 4A, arrows) and L-cells (Figure
4E, arrows). Although only rarely did PITP pixels appear
inside nuclei of either cell line, PITP was most intensely
labeled in the perinuclear region and throughout the cytoplasm. Caveolin-1 was localized primarily in the cytoplasm
(Figure 4B) and less so at the plasma membrane of hepatoma
cells (Figure 4B, arrows). In contrast, in L-cells caveolin-1
appeared much more at the plasma membranes (Figure 4F,
arrows). The overlay of green (PITP) and red (caveolin-1)
images showed codistribution of the two proteins primarily
around nuclei and in the cytoplasm of hepatoma cells (Figure
4C) but most intensely at the plasma membranes of L-cells
(Figure 4G, arrows). This pattern of intracellular colocalization was better visualized when only colocalized PITP
and caveolin-1 were shown (Figure 4D,H). Quantitative
analysis of pixel fluorograms of select plasma membrane
regions from multiple cells showed that about 72.2 ( 23.0
and 77.3 ( 16.4% of PITP (green) pixels were colocalized
with 81.4 ( 11.2 and 86.1 ( 9.0% of the caveolin-1 (red)
pixels in plasma membranes of hepatoma and L-cells,
respectively (Table 1). In hepatoma cell plasma membranes,
2.9-fold more PITP pixels overlapped with caveolin-1 as
compared to SCP-2 colocalizing with caveolin-1. In L-cell
plasma membranes, a comparable fraction of PITP and
SCP-2 (77.3 and 86.7%, respectively) overlapped with
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FIGURE 5: Fluorescence resonance energy transfer (FRET) between
Cy3-labeled PITP and Cy5-labeled caveolin-1 in L-cells. Cells were
probed with anti-caveolin1-Cy5 and anti-PITP-Cy3 conjugates. The
donor (Cy3) was excited with 568 nm band and detected through
HQ590/40 filter, while the acceptor (Cy5) was excited at 647 nm
band and detected through 680/20 filter. Panel A: Cy3 (PITP)
emission acquired with 568 nm band excitation, showing PITP
distribution. Panel B: Cy5 (caveolin-1) sensitized emission image
acquired with excitation of Cy3 at 568 nm, indicating no energy
transfer from Cy3(PITP) to Cy5 (caveolin-1). Panel C: Cy5
emission acquired with 647 nm band excitation, showing caveolin-1
distribution. Panel D: Cy3 fluorescence image acquired with
568 nm band excitation after photobleaching Cy5; no increase
in fluorescence of Cy3 after Cy5 photobleach was observed.
Panel E: postbleach Cy5 emission image with excitation of Cy3
at 568 nm. Panel F: postbleach Cy5 emission with 647 nm band
excitation.

FIGURE 4: Colocalization of PITP and caveolin-1 in hepatoma and
L-cells. PITP was probed with mouse anti-PITP and goat antimouse-IgG-FITC (green), while caveolin-1 was probed with
polyclonal rabbit anti-caveolin-1 and goat anti-rabbit-IgG-Rhodamine
Red X (red) in hepatoma (panels A-D) and L-cells (panels E-H).
Panels A and E: distribution of PITP in hepatoma (A) and L-cells
(E). Panels B and F: localization of caveolin-1 in hepatoma (B)
and L-cells (F). Panels C and G: overlay of PITP (green) and
caveolin-1 (red) images for hepatoma (C) and L-cells (G). Panels
D and H: images obtained by selecting the pixels with highest
degree of colocalization (yellow) in panels C and G, respectively.

caveolin-1 (Table 1). In summary, the colocalization of PITP
with caveolin-1 appeared to overlap in part with that of
SCP-2 with caveolin-1.
Specificity of FRET Analysis for Proximity of SCP-2 to
CaVeolin-1: Intermolecular Distance between PITP and
CaVeolin-1. As for FRET between SCP-2 and caveolin-1,
the FRET requirement for higher laser excitation power and
increased detection sensitivity (iris, gain, etc.) essential to
detect FRET also resulted in higher background and somewhat increased intensities of PITP and caveolin in nuclei
(Figure 5). Nevertheless, the intracellular distributions of
Cy3-anti-PITP (donor) (Figure 5A) and Cy5-anti-caveolin-1
(acceptor) (Figure 5C) were basically similar to those
detected by primary antibody/tagged-secondary antibody
techniques in L-cells (Figure 2). To determine if FRET
occurred from Cy3-labeled PITP (donor) to Cy5-labeled
caveolin-1 (acceptor), the possibility of sensitized emission
was examined. The Cy3 donor was excited at 568 nm, and
an image of Cy3-labeled PITP emission was acquired
through a 590/40 nm band filter (Figure 5A), and concomi-

tantly, the emission of Cy5-labeled caveolin-1 was recorded
through a 680/30 nm filter (Figure 5B). Since Cy5 is not
excited at 568 nm, the Cy5 emits upon FRET from Cy3
(excited at 568 nm) only if caveolin-1 and PITP are in close
proximity. Clearly, since Cy5-labeled caveolin-1 sensitized
emission was not detectable (Figure 5B); these molecules
were not in close proximity. To confirm the lack of
significant FRET, Cy3 donor emission was measured upon
prebleaching the Cy5 acceptor. Cy5-labeled caveolin-1
emitted strongly when Cy5 was directly excited at 647 nm
(Figure 5C), a wavelength at which Cy3 was not excited.
The Cy5 fluorescent molecules in the desired field were
photobleached by repeat scanning with 647 nm wavelength
for 15 min at laser power of 100%. After photobleaching,
the Cy5-labeled caveolin-1 was completely bleached (Figure
5E,F). The same photobleached area was then excited with
568 nm (Cy3 excitation), and a postbleach Cy3-labeled PITP
image was acquired (Figure 5D). The postbleach Cy3 image
intensity (Figure 8D) was very similar to that of the prebleach
image intensity (Figure 5A), consistent with weak (if any)
FRET between Cy3-tagged PITP and Cy5-tagged caveolin1. Examination of a large number of cells (n ) 25) showed
that the FRET efficiency between the Cy3-labeled PITP and
Cy-5-labeled caveolin-1 was <0.5%, and the distance r was
>120 Å. Since the distance r was larger than 2 × Ro, this
indicated no energy transfer between caveolin-1 and PITP
(38, 54).
Thus, caveolin-1 and PITP did not appear in sufficient
proximity for direct interaction. These data, together with
the close proximity (48 Å) between SCP-2 and caveolin-1,
were consistent with specific direct interaction between
SCP-2 and caveolin-1.

SCP-2 Interacts with Caveolin-1
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FIGURE 7: Fluorescence resonance energy transfer (FRET) between
Cy3-labeled PITP and Cy5-labeled SCP-2 in L-cells. SCP-2
overexpressing L-cells were fixed and probed for SCP-2 with antiSCP-2-Cy5 and for PITP with anti-PITP-Cy3 conjugates. The donor
(Cy3) was excited with 568 nm band and detected through HQ590/
40 filter, while the acceptor (Cy5) was excited at 647 nm band
and detected through 680/20 filter. Panel A: Cy3 (PITP) emission
acquired with 568 nm band excitation, showing PITP distribution.
Panel B: Cy5 (SCP-2) sensitized emission image acquired with
568 nm band excitation of Cy3, indicating the energy transfer from
Cy3 to Cy5. Panel C: Cy5 emission acquired with 647 nm band
excitation, showing SCP-2 distribution. Panel D: postbleach Cy3
emission acquired with 568 nm band excitation. Panel E: Postbleach Cy5 emission with excitation of Cy3 at 568 nm. Panel F:
Postbleach Cy5 emission acquired with 647 nm band excitation.

FIGURE 6: Intracellular distribution of SCP-2 and PITP in hepatoma
and L-cells. SCP-2 was probed with rabbit anti-SCP-2 polyclonal
antibody and goat anti-rabbit-IgG-Rhodamine Red X (red), while
PITP was probed with monoclonal mouse-anti-PITP and goat antimouse-IgG-FITC (green) in hepatoma (panels A-D) and L-cells
(panels E-H). Panels A and E: localization of SCP-2 in hepatoma
(A) and L-cells (E). Panels B and F: distribution of PITP in
hepatoma (B) and L-cells (F). Panels C and G: overlay of SCP-2
(red) and PITP (green) images for hepatoma (C) and L-cells (G).
Panels D and H: images obtained by selecting the pixels with
highest colocalization degree (yellow) in panels C and G, respectively.

Confocal Imaging of SCP-2 Codistribution with PITP.
Since immunolabeling and confocal microscopy showed that
some SCP-2 as well as PITP colocalize with caveolin-1, the
possibility that SCP-2 codistributes with PITP was examined.
Hepatoma and L-cells were double immunolabeled with antiSCP-2 and anti-PITP antibodies and examined by confocal
microscopy. SCP-2 (red) was localized primarily in the
cytoplasm (Figure 6A,E) and less so at the plasma membrane
in both hepatoma (Figure 6A, arrows) and L-cells (Figure
6E, arrows). In contrast, PITP (green) was highly distributed
in the perinuclear region and throughout the cytoplasm, but
significant PITP appeared at the plasma membrane in
hepatoma (Figure 6B, arrows) and L-cells (Figure 6F,
arrows). Relatively little PITP was detected in nuclei of either
cell line. The overlay of red (SCP-2) and green (PITP)
images shown for hepatoma cells (Figure 6C) and for L-cells
(Figure 6G) demonstrated a high degree of colocalized
yellow/orange pixels. After subtracting the background
pixels and displaying only colocalized pixels (yellow), the

FIGURE 8: Coimmunoprecipitation of SCP-2, caveolin-1, and PITP
from SCP-2 overexpressing L-cells. IP, immunoprecipitation of cell
lysate was performed with anti-SCP-2 or anti-caveolin-1, as
indicated for lanes 2 and 3; WB, Western blots were probed with
anti-SCP-2 (A), anti-caveolin-1 (B), and anti-PITP (C). Lane 1:
SCP-2 overexpressing L-cell lysate. Lane 2: immunocomplexes
precipitated by rabbit anti-SCP-2. Lane 3: immunocomplexes
precipitated by mouse anti-caveolin-1.

colocalized SCP-2/PITP appeared primarily in the perinuclear region and punctuate throughout the cytoplasm but
much less so at the plasma membranes in hepatoma (Figure
6D) or L-cells (Figure 6H). Quantitative analysis of pixel
fluorograms of select plasma membrane areas of multiple
cells revealed that the percentage colocalization of SCP-2
with PITP at the plasma membrane level was similar for
hepatoma and L-cells. At the plasma membrane a large
fraction (i.e., 80.1 ( 13.8 and 86.2 ( 14.8%) of SCP-2pixels colocalized with a smaller fraction (46.6 ( 26.9 and
32.9 ( 19.4%) of PITP pixels in hepatoma and L-cells,
respectively. The fractional number of SCP-2 pixels that
colocalized with caveolin-1 was 3.2-fold less than SCP-2
pixels overlapping with PITP in hepatoma plasma mem-
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branes (Table 1). In contrast, an equally high percentage of
SCP-2 pixels were found colocalized with PITP and with
caveolin-1 in L-cell plasma membranes. In summary, these
data indicated clearly that SCP-2 was colocalized with PITP
primarily in the perinuclear regions, cytoplasm, and somewhat less at the plasma membrane. This colocalization pattern
further supported the possibility that both SCP-2 and PITP
may contribute to cholesterol transfer and/or PI transfer and
PI signaling functions mediated through lipid rafts/caveolae.
Determination of Intermolecular Distance between SCP-2
and PITP in L-Cells: Fluorescence Resonance Energy
Transfer (FRET). To further resolve the spatial relationships
between SCP-2, caveolin-1, and PITP, the intermolecular
distance between SCP-2 and PITP was determined. To show
whether FRET occurred from Cy3-labeled PITP (donor) and
Cy5-labeled SCP-2, the possibility of sensitized emission was
examined. The Cy3 donor was excited at 568 nm, and an
image of Cy3-labeled PITP emission was acquired through
a 590/40 nm band filter (Figure 7A), and concomitantly, the
emission of Cy5-labeled SCP-2 was recorded through a 680/
30 nm filter (Figure 7B). Since Cy5 was not excited at 568
nm, the Cy5 emitted upon FRET from Cy3 (excited at 568
nm) only if SCP-2 and PITP were in close proximity. Since
Cy5-labeled SCP-2 sensitized emission detected from Cy3labeled PITP (Figure 7B) was significantly weaker than that
of Cy5-lableled caveolin-1 from Cy3-labeled SCP-2 (Figure
7B), this suggested that the SCP-2 was further from PITP
than from caveolin-1. To confirm this possibility, Cy3labeled PITP donor emission was measured upon prebleaching the Cy5-labeled SCP-2 acceptor. Cy5-labeled SCP-2
emitted strongly when Cy5 was directly excited at 647 nm
(Figure 7C), a wavelength at which Cy3 was not excited,
but not when the Cy5 fluorescent molecules in the desired
field were photobleached by repeat scanning with 647 nm
wavelength for 15 min at laser power of 100% (Figure 7E).
The same photobleached area was then excited at 568 nm
(Cy3 excitation), and a postbleach Cy3-labeled caveolin-1
image was acquired (Figure 7D). Although the postbleach
Cy3 image intensity (Figure 7D) was higher than that of the
prebleach image intensity (Figure 7A), FRET efficiency
between the Cy3-labeled PITP and Cy-5-labeled SCP-2 was
only 26 ( 3%, and the distance r was 61 ( 2 Å.
Since confocal FRET (i.e., 48 Å) and immunogold electron
microscopy showed that SCP-2 (but not PITP) was in close
proximity to caveolin-1 at the plasma membrane while FRET
microscopy indicated SCP-2 was within 61 Å of PITP, it
can be inferred that SCP-2 molecules interacting with PITP
were not bound to caveolin-1. Since PITP was sufficiently
close to SCP-2 for direct interaction, these data suggest that
PITP was localized either (i) more distant from SCP-2 and
caveolin-1 within caveolae, (ii) near but not within caveolae,
or (iii) near SCP-2 that was not associated with caveolae,
caveolar vesicles, or caveolin-chaperone complexes.
RelatiVe Codistribution and Colocalization of SCP-2 with
CaVeolin-1 as Compared to Peroxisomal Markers: Immunofluorescence Confocal Imaging and Immunogold Electron
Microscopy. As indicated previously, SCP-2, PITP, and
caveolin-1 were distributed not only at the plasma membrane
but also in the cytoplasm often in a punctate pattern. Since
previous studies demonstrated that in L-cells about 50% of
SCP-2 was associated with peroxisomes, while the rest of
SCP-2 was either diffuse in the cytosol or membrane-bound
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to various organelles (microsomes, mitochondria), the possibility that the punctate distribution of SCP-2 colocalized
with caveolin-1 or PITP reflected that of proximity to
peroxisomes rather was investigated.
Immunofluorescence confocal imaging and immunogold
electron microscopy showed that SCP-2, but not caveolin1, was highly distributed to peroxisomes. SCP-2 colocalization with catalase, a protein located inside peroxisomes, was
analyzed in SCP-2-overexpressing hepatoma cells by confocal microscopy of cells double immunolabeled with
antibody against SCP-2 and catalase (see Materials and
Methods). Both SCP-2 and catalase were detected as
punctuated structures distributed throughout the cytoplasm
(data not shown). Quantitative analysis by pixel fluorograms
indicated that approximately 45% of SCP-2 was colocalized
with 79% of catalase. Similar colocalization percentage was
also detected in mock-transfected control hepatoma cells (not
shown). These data further supported that a large portion
(∼50%) of SCP-2 existed outside the peroxisomes, consistent
with tissue fractionation and immunocytochemistry of liver
and other tissues (reviewed in ref 16). SCP-2 overexpressing
hepatoma cells were fixed and double immunolabeled with
anti-caveolin-1 antibody together with anti-peroxisomal
membrane protein-70 (anti-PMP70), found exclusively in
peroxisomal membranes. As for catalase, PMP70 was also
distributed as punctuate structures throughout the cytoplasm
(not shown). In contrast, in the cytoplasm, caveolin-1 was
stained much more diffusely and also punctuated structures
apparently smaller than peroxisomes. Quantitative analysis
of a pixel fluorogram of the superposed images showed that
only 28% of caveolin-1 was colocalized with 21% of PMP70.
Thus, caveolin-1 colocalized weakly with peroxisomes.
Immunogold electron microscopy confirmed that SCP-2, but
not caveolin-1, was detected in peroxisomes of SCP-2
overexpressing L-cells as shown by a representative image
(Figure 3C).
To examine whether the punctuate distribution of PITP
in cytoplasm of hepatoma and L-cells was associated with
peroxisomes, cells were double immunolabeled with antibodies against PITP and catalase and analyzed by confocal
microscopy. In the cytoplasm of hepatoma cells, both PITP
and catalase were detected primarily as separate PITP pixels
distinct from catalase pixels (data not shown). Quantitative
analysis by a pixel fluorogram indicated that only 23% of
PITP was colocalized with 100% of catalase. In cytoplasm
of L-cells, PITP and catalase also appeared separately (data
not shown). Enhancement and display of only colocalized
(yellow) pixels showed that some PITP colocalized with
catalase, in catalase-rich regions. This was confirmed by
quantitative analysis in the pixel fluorogram that showed only
22% of SCP-2 was colocalized with 74% of catalase.
Quantitative pixel fluorogram analysis showed that the
colocalization percentage was e23% in both hepatoma and
L-cells. In comparison, 46% of SCP-2 codistributed with
catalase in L-cells. These data demonstrated that PITP was
much less (i.e., 2-fold) codistributed with peroxisomes as
compared to SCP-2.
In summary, immunofluorescence confocal imaging and
immunogold electron microscopy indicated that (i) SCP-2
was highly localized in peroxisomes, (ii) caveolin-1 was not
detectable in peroxisomes, and (iii) PITP was only weakly
colocalized with peroxisomes. These data indicated that SCP-
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2, but not caveolin-1, localized in the cytoplasm within
peroxisomes. Likewise, PITP also appeared poorly associated
with peroxisomes. Thus, intracellular colocalization of SCP-2
with caveolin-1 was not due to caveolin-1 localization near
or within peroxisomes.
Coimmunoprecipitation of SCP-2 with CaVeolin-1. To
confirm the previous FRET data suggesting direct interaction
between SCP-2 and caveolin-1, SCP-2 and caveolin-1 were
coimmunoprecipitated from L-cells overexpressing SCP-2.
When lysates of L-cells overexpressing SCP-2 were individually probed with anti-SCP-2 or anti-caveolin-1 antibodies, it was evident that the L-cells contained much more
SCP-2 than caveolin-1 (Figure 8A,B, lane 1). When lysates
were immunoprecipitated with anti-SCP-2 or anti-caveolinantibodies, the immunprecipitates were enriched in SCP-2
(Figure 8A, lane 2) and caveolin-1 (Figure 8B, lane 3),
respectively, as compared to the amounts of these proteins
present in the lysate (Figure 8A,B, lane 1). Anti-SCP-2
antibody successfully coimmunoprecipitated caveolin-1 (Figure 8B, lane 2) along with SCP-2 (Figure 8A, lane 2). The
caveolin-1 band (Figure 8B, lane 2) was severalfold ernriched
as compared to caveolin-1 present in the cell lysate (Figure
8B, lane 1). Anti-caveolin-1 antibody successfully precipitated caveolin-1 (Figure 8B, lane 3) and coprecipitated SCP-2
(Figure 8A, lane 3) from homogenates of SCP-2 overexpressing L-cells. The coimmunoprecipitated SCP-2 band
(Figure 8A, lane 3) was severalfold more intense than the
amount of SCP-2 present in the cell lysate (Figure 8A, lane
1). Likewise, the caveolin-1 band (Figure 8B, lane 3) was
severalfold more intense that in the cell lysate (Figure 8B,
lane 1). Since both anti-caveolin-1 and anti-SCP-2 coimmunoprecipitated similarly large amounts of SCP-2 but
much less caveolin-1, this experiment suggests that a
significant amount of SCP-2 interacted with caveolin-1. Thus,
SCP-2 and caveolin-1 were coimmunoprecipitated by antiSCP-2 or anti-caveolin-1 antibodies. These data further
supported the possibility that SCP-2 directly interacted with
caveolin-1.
Specificity of SCP-2 Coimmunoprecipitation with CaVeolin-1. To determine the specificity of SCP-2 coimmunoprecipitation with caveolin-1, coimmunoprecipitation with PITP
was examined in homogenates from SCP-2 overexpressing
L-cells. Neither anti-SCP-2 nor anti-caveolin-1 antibody
coimunnoprecipitated PITP (Figure 8C, lanes 2 and 3,
respectively). Since the commercially available monoclonal
anti-PITP antibody failed to precipitate PITP under the same
precipitation condition used for precipitating caveolin-1 and
SCP-2, this precluded direct coimmunoprecipitations with
anti-PITP. However, this antibody recognized PITP from
Western blots of the cell lysates (Figure 8C, lane 1). In
summary, neither anti-SCP-2 nor anti-caveolin-1 coimmunoprecipitated PITP. These data further supported the possibility
that the direct interaction of SCP-2 with caveolin-1 was
specific.
Cellular Subfractionation to Determine if SCP-2 Distributed to CaVeolae/Lipid Rafts Isolated from SCP-2 OVerexpressing L-Cells. To determine if SCP-2 was associated with
caveolae/lipid rafts purified by subcellular fractionation,
plasma membranes were isolated from mock-transfected
(control) L-cells and SCP-2 overexpressing L-cells as
described in Materials and Methods. The resultant purified
plasma membranes were then further subjected to con-
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FIGURE 9: Western blotting of SCP-2 and PITP in plasma
membranes, caveolae/lipid raft domains, and nonraft domains.
Western blotting was performed as described in Materials and
Methods. Equal quantities of protein from mock transfected control
L-cells (lanes 1-3) and SCP-2 overexpressing L-cells (lanes 4-6)
were loaded in each lane: lanes 1 and 4, plasma membrane; lanes
2 and 5, nonraft fraction; and lanes 3 and 6, caveolae/lipid raft
fraction. Panel A was detected with anti-SCP-2, while panel B was
detected with anti-PITP.

canavalin-A affinity chromatography to resolve a nonadherent and an adherent fraction. Western blotting with antiSCP-2 antisera suggested that SCP-2 levels were below the
limit of detection in purified plasma membranes from control
(mock-transfected) L-cells (Figure 9A, lane 1). However,
when these plasma membranes were subfractionated by
concanavalin-A affinity chromatography, the caveolae/lipid
raft fraction contained detectable SCP-2 (Figure 9A, lane
3), while the nonraft fraction contained no detectable SCP-2
(Figure 9A, lane 2). For SCP-2 overexpressing cells, Western
blotting with anti-SCP-2 antisera detected a significant
amount of SCP-2 in purified plasma membranes (Figure 9A,
lane 4), as well as in the caveolae/lipid raft fraction (Figure
9A, lane 6), but not the nonraft fraction (Figure 9A, lane 5).
The amount of SCP-2 detected in the caveolae/lipid raft
fraction of SCP-2 overexpressing cells (Figure 9A, lane 6)
appeared greater than for control cells (Figure 9A, lane 3).
It should be noted that, although the caveolae/lipid raft
fraction contained bound SCP-2, the level of SCP-2 was less
than in the plasma membrane fraction. This apparent loss of
SCP-2 may be due to the fact that SCP-2 is not an integral
membrane protein but interacts with the membrane fractions
through electrostatic interactions with anionic phospholipids
(and/or putative receptor proteins). Because of the volumes
involved, SCP-2 was apparently partially lost during the
conA affinity chromatography of the plasma membrane
fraction to resolve caveolae/lipid rafts from nonraft membrane domains. In summary, SCP-2 was detectable in highly
purified plasma membranes isolated by cellular subfractionation. Further resolution of caveolae/lipid rafts from nonraft
regions of the plasma membrane revealed that SCP-2 was
preferentially localized in caveolae/lipid rafts.
Specificity of SCP-2 Distribution to CaVeolae/Lipid Rafts
Isolated by Subcellular Fractionation of SCP-2 OVerexpressing L-Cells. Western blotting with anti-PITP antisera
detected PITP in the plasma membrane fraction of control
L-cells (Figure 9B, lane 1). When these plasma membranes
were subfractionated by concanavalin-A affinity chromatography, the caveolae/lipid raft fraction contained more PITP
(Figure 9B, lane 3) than the nonraft fraction (Figure 9B, lane
2). For SCP-2 overexpressing cells (contain 4-fold more total
SCP-2 than controls), Western blotting with anti-PITP
antisera detected PITP in plasma membranes (Figure 9B, lane
4) and the caveolae/lipid raft fraction (Figure 9B, lane 6),
but it was barely detectable in the nonraft fraction (Figure
9B, lane 5). Again, although the caveolae/lipid raft fraction
contained bound PITP, the level of PITP was less than in
the plasma membrane fraction. As for SCP-2 in the preceding
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section, this may be due to the fact that PITP also interacts
with membranes through electrostatic interactions with
anionic phospholipids (and/or putative receptor proteins). The
losses may be accounted for at least in part to dilutions and
conA affinity chromatography of the plasma membrane
fraction to resolve caveolae/lipid rafts from nonraft membrane domains. Since PITP was detected in caveolae/lipid
rafts, but not coimmunoprecipitated by either anti-SCP-2 or
anti-caveolin-1, these data indicate that the PITP most likely
was associated with the noncaveolar lipid rafts.
Yeast Two-Hybrid Assay to Determine Interaction between
SCP-2 and CaVeolin-1 in ViVo: Constructs and Yeast
Expression. Since the previous biochemical and immunolabeling approaches were all in vitro methods that were
antibody-dependent, these studies were complimented by an
in vivo approach that was antibody-independent. The yeast
two-hybrid assay was used to determine a protein-protein
interaction between SCP2 and caveolin-1 in vivo. All
reagents and basic procedures (48-50) for the yeast twohybrid assay were performed exactly as described in Materials and Methods. Briefly, SCP-2 cDNA was excised from a
mammalian SCP-2 overexpression plasmid and ligated into
the entry clone, pENTR11; the recombinant plasmid, pENTRSCP2 (Figure 10A, right panel) was restriction enzyme
digested, sequence verified, and used to subclone SCP-2 into
the activating domain fusion (AD-Y) and DNA binding
domain fusion (BD-X). SCP-2 was cloned into pDEST22,
encoding the activation domain of the Gal4 transcription
factor, producing the fusion protein, AD-SCP2 (Figure 10B,
bottom left). Likewise, SCP-2 was cloned into pDEST32,
encoding the binding domain of the Gal4 transcription factor,
producing the fusion protein, BD-SCP2 (Figure 10B, bottom
right). Western blot analyses confirmed the expression of
the fusion protein for SCP-2 (Figure 11A) in yeast cell
lysates. The fusion protein with SCP-2 has a molecular
weight of ∼30 kDa.
Similarly, the caveolin-1 cDNA was generated and ligated
into the entry clone, pENTR11, as described in Materials
and Methods. The new plasmid, pENTR-caveolin-1 (Figure
10A, left panel) was restriction enzyme digested, sequence
verified, and used to subclone caveolin-1 into pDEST22
producing the Gal4 activating domain-caveolin-1 fusion
protein (Figure 10B, top left) and pDEST32 producing the
Gal4 DNA binding domain-caveolin-1 fusion protein (Figure
10B, lower right), respectively. Western blot analyses
confirmed the expression of the fusion protein for caveolin-1
(Figure 11B) in yeast cell lysates. The fusion protein with
caveolin-1 SCP-2 has a molecular weight of ∼38 kDa.
Separate yeast two-hybrid experiments were performed
using both AD-SCP2 with BD-caveolin-1 and AD-caveolin-1
with BD-SCP2, and both assays were repeated twice. We
obtained the same results from all assays.
Yeast Two-Hybrid Assay: Control Strain Growth Patterns.
S. cereVisiae strain MaV203 was used to test for interactions
of caveolin-1 and SCP-2, and each assay plate contained a
panel of MaV103 (MATa) control strains described in
Materials and Methods. Growth phenotypes of five yeast
control strains produced with the transformation of MaV103
with plasmids encoding DNA binding-fusion proteins and
activating domain-fusion proteins demonstrating no interaction (Figure 12A, control A), weak interaction (Figure 12A,
control B), moderate interaction (Figure 12A, control C),
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Table 2: CPRGa Analyses for β-Galactosidase Activity in Yeast
Two-Hybrid Assay
clone

β-gal unitsb

positive control
negative control
clone 16 (pD22SCP2 + pD32caveolin-1)
clone 1 (pD22SCP2 + pD32caveolin-1)
clone 2 (pD22SCP2 + pD32caveolin-1)

0.23
0.09
0.280
0.202
0.240

a
Chlorophenol red β-D-galactopyranoside (CPRG). b β-gal units )
1000 OD570/tmin volume OD600.

strong interaction (Figure 12A, control D), and very strong
interaction (Figure 12A, control E). Yeast were grown on
complete synthetic media (CSM) lacking either leucine (L),
tryptophan (T), uracil (U), and/or histidine(H) with 3-amino1,2,4-triazole (3AT) or 5-fluoroorotic acid (5FOA) as
described (Figure 12A). Growth was measured after incubation at for 48 h at 30 °C. Positive interactions were detected
by growth on CSM-L-T, CSM-L-T-H + with less than 50
mM 3AT, CSM-L-T-U, and no growth on CSM-L-T + 0.2%
5FOA. In addition, positive interactions were indicated by
no growth on CSM-L-T-U but growth on all the other media.
Yeast Two-Hybrid Assay: Growth Patterns of Strains
Expressing SCP-2 and CaVeolin-1. Growth phenotypes of
the strain MaV203 cotransformed with pDEST22-SCP2
(producing the DNA binding fusion protein, DB-SCP2) and
pDEST32-caveolin-1 (producing the activating domain fusion
protein, AD-caveolin-1) were determined as described in
Materials and Methods. Three individual Leu+, Trp+
transformants, clones 1, 2, and 16 were grown on CSM-LT, CSM-L-T-H + 3AT (12.5, 50, and 100 mM), CSM-LT-U, and CSM-L-T + 0.2% 5FOA (Figure 12B). Plates were
incubated at 30 °C for 48 h and observed for growth. Growth
on CSM-L-T, CSM-L-T-H + 3AT with less than 50 mM
3AT, weak to no growth on CSM-L-T-U, and no growth on
CSM-L-T + 0.2% 5FOA were considered positive interactions.
Positive SCP-2-caveolin-1 interactions were identified by
(i) the induction of the URA3 gene by weak to no growth
on CSM-Leu-Trp-Ura plates and the inhibition of growth
on CSM-Leu-Trp + 0.2% 5FOA (Figure 12B). (ii) Induction
of the HIS3 gene was demonstrated by showing an increased
dose-dependent level of inhibition of growth on CSM-Leu,
-Trp, and -His + 3AT (Figure 12B). (iii) Induction of the
lacZ gene was observed in positive yeast colonies turning a
blue color when assayed qualitatively on nitrocellulose
membranes using X-gal (data not shown) and quantitatively
by assaying for β-galactosidase using chlorophenol red β-Dgalactopyranoside (CPRG) assay (Table 2). Similar data (not
shown) were obtained when SCP-2 and caveolin-1 were
fused oppositely to, respectively, the Gal4 DNA binding and
activating domains pDEST32-SCP-2 (i.e., BD-SCP-2) and
pDEST22-caveolin-1 (i.e., AD-caveolin-1).
In summary, the yeast two-hybrid assay demonstrated a
protein-protein interaction between SCP-2 and caveolin-1
in vivo, consistent with the immunocolocalization, FRET,
and immunoprecipitation data in the preceding sections.
DISCUSSION
Since both HDL-mediated reverse-cholesterol transport
(11, 61) as well as a significant portion of phosphoinositide
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FIGURE 10: Vectors for the yeast two-hybrid assay. Panel A: Gateway entry clones using the shuttle vector, pENTR11, to develop pENTRSCP2 and pENTR-caveolin-1 were prepared by cloning SCP2 and caveolin-1 genes, respectively, into NcoI and XhoI or XmnI and XhoI
restriction enzyme sites. Both inserts are flanked by attL1 and attL2 recombination sites that are used in a phage λ-based site-specific
recombination event to shuttle the SCP2 and caveolin-1 into the Gateway expression vectors. The entry clones contain a pUC origin of
replication and the kanamycin resistance gene (Kmr) for maintenance in E. coli. Panel B: Gateway DEST clones using the expression
vectors, pDEST22 and pDEST32, to use in the ProQuest Yeast Two-Hybrid System (Invitrogen), pDEST22-caveolin-1 (upper left), and
pDEST22-SCP2 (lower left) encode fusion proteins containing the transcription activating domain (AD) of the GAL4 transcription factor
(generating AD-Y). The pDEST22 clones contain a pUC origin of replication and the ampicillin resistance gene (Apr), while the pDEST32
clones encode a gentamycin resistance gene (Gmr) for maintenance in E. coli. The attB1 and attB2 sites flanking the fusion proteins are
the result of attL (from pENTR vector) and attR (from pDEST vector) site-specific recombination. For expression in yeast, the fusion
proteins are under the alcohol dehydrogenase promoter (pADH) with a nuclear localization signal (NLS) and encode for either tryptophan
(pDEST22) or leucine (pDEST32) for selection on media without the respective amino acids.

signaling (2, 11, 62) are mediated through plasma membrane
microdomains termed caveolae/lipid rafts, it is important to
resolve the mechanism(s) whereby these lipids traffic from
intracellular sites of synthesis and are targeted to caveolae/
lipid rafts. Cholesterol transport to caveolae/ lipid rafts occurs
by at least two pathways. (i) De novo synthesized cholesterol
traffics rapidly (1-2 min) from the endoplasmic reticulum
to plasma membrane caveolae/lipid rafts (reviewed in refs
63-67). This rapid cholesterol transport appears mediated
by cholesterol binding proteins such as SCP-2 and/or a

caveolin-1 complex with cholesterol and chaperone proteins
(reviewed in refs 7, 15, and 17). Although SCP-2 is primarily
a soluble protein, some SCP-2 has been reported associated
with endoplasmic reticulum in fixed cells and in isolated
microsomes (reviewed in ref 16). (ii) Exogenous derived
cholesterol (LDL-receptor/lysosomal endocytic pathway) first
traffics from lysosomes to the plasma membrane (reviewed
in refs 7, 15, and 16) or endoplasmic reticulum (19) by rapid
protein-mediated transport (e.g., SCP-2) and/or by vesicular
transport via the Golgi network (reviewed in refs 7, 15, and
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FIGURE 11: Western blot analyses of yeast cell lysates from clones
containing pD22SCP2 and pD32caveolin-1. Cell lysates from
untransfected MaV203 (lane 1), clone 16 (lane 2), and clone 1 (lane
3) were separated on 12% polyacrylamide (SDS) gels and transferred to nitrocellulose membranes. The blots were probed with
(A) rabbit anti-SCP2 antisera or (B) rabbit anti-caveolin-1 antisera
and horseradish conjugated-goat anti-rabbit immunoglobulin G.
Antibody binding was detected as described in Materials and
Methods.

16). Interestingly, both SCP-2 (16, 68) and PITP (23) bind
long chain fatty acyl CoA (LCFA-CoA), and both SCP-2
(23) and PITP (23, 59) bind phosphatidylinositol (PI) and
phosphatidylpolyphosphoinositides (poly-PIs). LCFA-CoAs
(69, 70) and PIs (reviewed in ref 20) are potent mediators
involved in vesicle budding from the Golgi. PITP is known
to stimulate vesicle budding from Golgi (reviewed in ref 20).
Taken together, these data suggest that the intracellular
cholesterol binding proteins (SCP-2, caveolin-1) as well as
PI binding proteins (SCP-2, PITP) may participate directly
or indirectly in cholesterol trafficking from endoplasmic
reticulum/Golgi to plasma membrane caveolae/lipid rafts.
Although the previous earlier studies clearly show an involvement of SCP-2 and caveolin-1 in cholesterol trafficking
to plasma membrane caveolae/lipid rafts, almost nothing is
known regarding mechanism(s) and potential molecular
interactions between these proteins in caveolar vesicles and
at the target of cholesterol delivery (i.e., caveolae/lipid rafts).
To date, only a preliminary report colocalized some SCP-2
with caveolin-1 (23). However, the limit of resolution of light
microscopy (i.e., 2200 Å) precluded differentiation of
whether SCP-2 was actually localized in plasma membrane
caveolae and/or caveolar vesicles. The data presented herein
make the following new contributions to our understanding
of the role of SCP-2 in mediating ligand transfer to plasma
membrane caveolae/lipid rafts.
First, double immunolabeling and laser scanning microscopy showed that a significant portion of SCP-2 was
colocalized with caveolin-1 (i.e., within 2200 Å), not only
in the cytoplasm but also at the plasma membrane of L-cell
fibroblasts and hepatoma cells. Within the cytoplasm, the
SCP-2 colocalized with caveolin-1 appeared both punctuate
and diffuse suggesting that SCP-2/caveolin-1 complexes were
membrane-bound and/or diffuse in the cytosol. The punctuate
distribution of SCP-2/caveolin-1 codistribution in cytoplasm
was distinct from that of SCP-2 and peroxisomes. Although
SCP-2 is present in highest concentration in peroxisomes in
a punctuate pattern, nearly half of total SCP-2 is extraperoxisomal in L-cells, hepatoma cells, and a variety of tissues
(reviewed in ref 16). Colocalization of SCP-2 with caveolin-1
was significantly greater than colocalization with peroxisomal
markersssuggesting SCP-2 colocalization was not just due
to caveolar vesicles appearing in the vicinity of peroxisomes
within the limit of resolution of optical microscopy (2200
Å). Finally, some of the SCP-2/caveolin-1 colocalized pixels
in the cytoplasm also appeared diffuse, consistent with the
fact that about 10% of caveolin-1 also exists as a soluble
caveolin-1/chaperonin/cholesterol complex in the cytosol
(17).
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Second, cellular subfractionation and immunocoprecipitation studies with SCP-2 overexpressing L-cells and Western
blotting further supported the codistribution of SCP-2 and
caveolin-1 in plasma membrane caveolae. Western blotting
detected SCP-2 in purified plasma membranes, especially
in the caveolae/lipid raft as compared to nonraft fraction.
Immunoprecipitation studies were consistent with SCP-2 and
caveolin-1 interacting in the soluble, cytoplasmic portion of
the cell. Anti-SCP-2 and anti-caveolin-1 both coimmunoprecipitated SCP-2 and caveolin-1 from cell lysates of SCP-2
overexpressing L-cells. These data for the first time demonstrated that SCP-2 was not only colocalized with caveolin-1 at the plasma membrane caveolae but also with
caveolae/lipid rafts isolated by subcellular fractionation and
with caveolin in the cytosol.
Third, fluorescence resonance energy transfer (FRET)
distinguished for the first time that SCP-2 was in sufficient
proximity for direct interaction with caveolin-1 at the plasma
membrane (caveolae) and in the cytoplasm (caveolar vesicles
and caveolin/chaperone complexes). FRET detected SCP-2
in close proximity (48 ( 4 Å) to caveolin-1 in L-cells. These
data show for the first time that SCP-2 was localized at the
plasma membrane and in the cytoplasm in close proximity
to caveolin-1 as in plasma membrane caveolae, caveolar
vesicles, and/or caveolin-1/ chaperone/cholesterol complexes.
Interestingly, SCP-2 overexpression in cultured L-cells
inhibits HDL-mediated cholesterol efflux through plasma
membrane caveolae mediated by vesicles but accelerates
protein-mediated cholesterol transport (32). Since the vesicular transport accounts for about 80% of total sterol efflux
through caveolae (32, 71), the net effect of SCP-2 was to
inhibit sterol efflux. The present data contribute to our
understanding of these observations. By directly binding
caveolin-1 at the plasma membrane and in cytoplasm, SCP-2
may block the transfer of cholesterol to caveolin-1. Precedent
for direct interaction of caveolin-1 with another protein
resulting in inhibition of activity is based on studies with
endothelial nitric oxide synthase (eNOS). When associated
with caveolin-1, the eNOS is inhibited, while uncomplexed
eNOS is functionally active (72). Thus, although caveolin-1
is very important for organizing signaling molecules and
proteins in caveolar structures, direct interaction of caveolin-1
with some proteins (eNOS, SCP-2) results in inhibition of
the action of either the interacting protein (eNOS) or
caveolin-1.
Fourth, the localization, immunoprecipitation, and proximity of SCP-2 with caveolin-1 were specific. As compared to
SCP-2, PITP was less colocalized to caveolin at the plasma
membrane, did not colocalize with peroxisomes, did not
coimmunoprecipitate with caveolin-1 or SCP-2, and was not
in sufficient FRET proximity for direct binding to caveolin1. Since FRET demonstrated that a fraction of SCP-2 was
within 61 ( 2 Å distance of PITP, while PITP was >120 Å
away from caveolin-1, this suggested that PITP was near,
but could actually be outside, caveolae. This was consistent
with the fact that (i) phosphatidylinositol 4-phosphate
synthesis occurs both in caveolae and even more so in
noncaveolar lipid rafts and (ii) PITP stimulates PI-4-kinase
activity in both immunoisolated caveolae and lipid rafts (14).
The fact that double immunolabeling confocal microscopy
colocalized a significant part of SCP-2 and PITP with
caveolin-1 at the plasma membrane for the first time provided
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FIGURE 12: Yeast two-hybrid assay examining interaction between caveolin-1 and SCP-2. Panel A: growth phenotypes of five yeast
control strains produced with the transformation of MaV103 with plasmids encoding DNA binding-fusion proteins and activating domainfusion proteins demonstrating no interaction (control A), weak interaction (control B), moderate interaction (control C), strong interaction
(control D), and very strong interaction (control E). Patches of cells were grown on complete synthetic media lacking leucine (L), tryptophan
(T), uracil (U), and/or histidine(H) with 3-amino-1,2,4-triazole (3AT) or 5-fluoroortic acid (5FOA) [CSM-L-T, CSM-L-T-H + 3AT (12.5,
50, and 100 mM), CSM-L-T-U, and CSM-L-T + 0.2% 5FOA]. The plates were incubated at 30 °C for 48 h and observed for growth.
Growth on CSM-L-T, CSM-L-T-H + with less than 50 mM 3AT), CSM-L-T-U, and no growth on CSM-L-T + 0.2% 5FOA were considered
positive interactions. No growth on CSM-L-T-U with growth on all the other media was also considered as a positive interaction. Panel B:
growth phenotypes of the strain MaV203 cotransformed with pDEST22-SCP2 (DB-SCP2 DNA binding fusion protein) and pDEST32caveolin-1 (AD-caveolin-1 activating domain fusion protein) were determined. Three individual Leu+; Trp+ transformants; and clones 1,
2, and 16 were grown on CSM-L-T, CSM-L-T-H + 3AT (12.5, 50, and 100 mM), CSM-L-T-U, and CSM-L-T + 0.2% 5FOA. The plates
were incubated at 30 °C for 48 h and observed for growth. Growth on CSM-L-T, CSM-L-T-H + 3AT with less than 50 mM 3AT),
CSM-L-T-U, and weak to no growth on CSM-L-T + 0.2% 5FOA were considered positive interactions.

ultrastructural evidence consistent with the hypothesis that
these proteins also potentially deliver phosphatidylinositol
(PI) to signaling complexes (receptors, phospholipase C, PI4
kinase, PI5 kinase) present in caveolae/lipid rafts (reviewed
in ref 20). Finally, while SCP-2 specifically inhibited
vesicular transport of cholesterol to plasma membrane (32),
in contrast, PITIP activates Golgi-vesiculation (reviewed in
refs 20 and 73). Thus, while sharing multiple ligand
specificities (PI, LCFA-CoA) and in vitro activities (reviewed
in refs 20, 23, and 73), SCP-2 and PITP may exert opposing
influences on functions such as cholesterol efflux.
Fifth, in addition to these data obtained in vitro, a yeast
two-hybrid assay demonstrated the protein-protein interaction between SCP-2 and caveolin-1 in vivo. The advantages
of the ProQuest yeast two-hybrid system with Gateway
technology are as follows: (1) that a positive interaction

depends on the induction of three independent genes at
different loci; (2) it provides four phenotypes [His+ (3ATR),
β-gal, Ura+, and 5FOAS]; and (3) the vectors are low copy
plasmids (ARS/CEN6 sequence for replication) to reduce the
expression levels and prevent toxicity to the yeast. As
detected by growth in culture and galactosidase activity, the
yeast two-hybrid assay in both directions showed positive
interaction of SCP2 with caveolin-1. Although the interaction
detected in the yeast-two hybrid assay was fairly small,
nevertheless it was positive.
While the molecular basis for SCP-2 interaction with
caveolin-1 remains to be resolved, sequence analysis provides
some insights. Caveolin-1 is known to have a scaffolding
domain (amino acids 80-101 through which many, but not
all, caveolin-1-interacting proteins interact with caveolin-1
(74)). Proteins that interact with the caveolin-1 scaffolding
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domain contain amino acid sequences of YXYXXXY or
YXXXXYXY where Y is aromatic (74). Since SCP-2 does
not contain either of these types of sequences, it represents
a protein that does not have a consensus sequence for
interaction with the scaffolding domain of caveolin-1.
The physiological significance of a small portion of total
SCP-2 interacting with caveolin-1, especially at the plasma
membrane, may be rationalized within the context of the
effects of SCP-2 overexpression on functions mediated
through caveolae/lipid rafts. For example, SCP-2 overexpression in L-cells dramatically alters the structure, cholesterol, phosphatidylinositol content, and cholesterol dynamics
of lipid rafts/caveolae isolated from these cells (75, 75).
Furthermore, SCP-2 overexpression reduces HDL-mediated
cholesterol efflux through caveolae (32) and enhances
intracellular cycling of cholesterol (29). Caveolin-1 is
primarily a membrane structural protein that favors concentration of cholesterol within specific regions of plasma
membranes, while SCP-2 is a protein that binds, circulates
within the cytosol, and exchanges cholesterol with various
membrane bound organelles, down the concentration gradient
of cholesterol. These proteins appear to have opposite
functions: caveolin-1 accumulates, makes a local pool of
cholesterol; SCP-2 equally distributes cholesterol and other
membrane lipid components among all the intracellular
membranes. Previous work has demonstrated that SCP-2
overexpression in L-cells resulted in inhibition of HDLmediated cholesterol efflux at caveolar location. The finding
that a fraction of SCP-2 is located in the caveolae and
physically interacts with caveolin-1 indicates a possible
molecular mechanism to explain this physiological effect of
SCP-2 in L-cells. How cholesterol is channeled from
caveolae to HDL or vice-versa through the SR-BI receptor
is poorly understood, and the effect of SCP-2 on this process
is still to be studied. A similar inhibitory action has been
observed upon eNOS interaction with caveolin-1 (72).
Finally, SCP-2 interaction with caveolin-1 contributes significantly to our understanding of how phosphatidylinositol
may be targeted from intracellular sites of synthesis in the
endoplasmic reticulum to caveolae/lipid rafts at the cell
surface plasma membrane. The interaction of SCP-2 with
caveolin-1 in plasma membrane caveolae may facilitate
transfer of bound PI ligand to the phosphatidylinositol
4-kinase signaling complex and thereby contribute to the
enhancement of phospholipase C mediated inositol-3phosphate production in SCP-2 overexpressing cells (23).
Interestingly, SCP-2 (but not PITP) colocalized within a few
angstroms of caveolin-1, and SCP-2 (but not PITP) was
coimmunoprecipitated with antisera to caveolin-1 or antisera
to SCP-2. This suggests that, although PITP stimulates the
phospholipase C signaling complex in plasma membrane
caveolae (23), the mechanism observed with SCP-2 is
distinct.
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